Biotricity, Inc.
BTCY
$0.48
-$0.02-4.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.81% | 65.28% | -57.48% | 21.30% | 57.73% |
| Total Depreciation and Amortization | 15,026.67% | -99.64% | 27,300.00% | -99.25% | 13,220.00% |
| Total Amortization of Deferred Charges | 31.58% | -6.40% | -43.63% | -14.36% | -70.31% |
| Total Other Non-Cash Items | -171.93% | -91.21% | 763.79% | 346.70% | -107.91% |
| Change in Net Operating Assets | 7,636.00% | 101.79% | -183.20% | -3.42% | 355.76% |
| Cash from Operations | 211.30% | 6.84% | -354.94% | 77.81% | 73.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -32.43% | -11.16% | -30.30% | 14.17% | -- |
| Total Debt Repaid | -- | -- | -15.44% | 50.24% | -1.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -68.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.39% | 3.28% | -3.39% | 1.67% | 50.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -216.53% | 164.06% | -61.18% | -9.79% | -45.74% |
| Foreign Exchange rate Adjustments | 125.69% | -139.65% | 18,360.00% | 66.67% | 97.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -417.24% | 118.06% | -142.97% | 363.86% | 110.58% |